Saturday, July 12, 2025
19.2 C
London
HomeFinTechIncannex Healthcare: Receives ethics approval for OSA trial

Incannex Healthcare: Receives ethics approval for OSA trial

Date:

UK Chancellor Reverses ISAs Reductions After Public Backlash

A bold move by the Chancellor to protect savers...

Binance Launches Sharia Earn: An Islamic Banking-Aligned Token

Discover how Binance's new offering caters to Islamic financial...

Ageras Expands Portfolio with 8th Acquisition: Payroll Provider Employes

Strategic Move to Enhance Services in the Accounting and...
  • Incannex Healthcare has received ethics approval for a phase 2b clinical trial investigating its obstructive sleep apnoea (OSA) treatment
  • OSA occurs when the airway at the back of the throat becomes blocked
  • As a result, the brain and body become oxygen deprived and the sleeper may wake up multiple times throughout the night
  • The upcoming trial will assess the therapeutic benefit of Incannex’s IHL-42X treatment at three different dose levels
  • The primary endpoint will a reduction in the apnoea hypopnea index (AHI) compared to the baseline level
  • Incannex is up 5.45 per cent on the market and shares are trading for 5.8 cents each

Related stories

spot_img

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Latest stories